Current report filing


Aug. 16, 2021
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description On August 18, 2021, Corbus Pharmaceuticals Holdings, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) to report Barbara White’s resignation as Chief Medical Officer. The Company is filing this amendment to the Original Form 8-K to disclose the terms of the Separation and General Release Agreement and the Consulting Agreement, each agreement by and between Dr. White and the Company. No other modifications have been made to the Original Form 8-K.
Document Period End Date Aug. 16, 2021
Entity File Number 001-37348
Entity Central Index Key 0001595097
Entity Tax Identification Number 46-4348039
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 500 River Ridge Drive
Entity Address, City or Town Norwood
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02062
City Area Code (617)
Local Phone Number 963-0100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol CRBP
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Information, Former Legal or Registered Name Not Applicable